Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K/A Current report
- 10.37 EX-10.37
- 10.38 EX-10.38
- 10.39 EX-10.39
- 10.40 EX-10.40
- 10.41 EX-10.41
- 10.42 EX-10.42
- 10.43 EX-10.43
- 10.44 EX-10.44
- 10.45 EX-10.45
- 10.46 EX-10.46
- 10.47 EX-10.47
- 10.48 EX-10.48
- 10.49 EX-10.49
- 10.50 EX-10.50
- 10.51 EX-10.51
- 10.52 EX-10.52
- 10.53 EX-10.53
- 10.54 EX-10.54
- 10.55 EX-10.55
- 10.56 EX-10.56
- 10.57 EX-10.57
- 10.58 EX-10.58
- 10.59 EX-10.59
- 10.60 EX-10.60
- 10.61 EX-10.61
- 10.62 EX-10.62
- 10.63 EX-10.63
- 10.64 EX-10.64
- 10.65 EX-10.65
- 10.66 EX-10.66
- 10.67 EX-10.67
- 10.68 EX-10.68
- 10.69 EX-10.69
- 10.70 EX-10.70
- 10.71 EX-10.71
- 10.72 EX-10.72
- 16.1 EX-16.1
- 21.1 EX-21.1
- 99.1 Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Unregistered Sales of Equity Securities; Material Modifications to Rights of Security Holders; Changes in Registrant's Certifying Accountant; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics; Change in Shell Company Status; Financial Statements and Exhibits
- Download Excel data file
- View Excel data file
OCEAW similar filings
- 17 Mar 23 Regulation FD Disclosure
- 17 Feb 23 Entry into a Material Definitive Agreement
- 15 Feb 23 Regulation FD Disclosure
- 15 Feb 23 Entry into a Material Definitive Agreement
- 13 Feb 23 Entry into a Material Definitive Agreement
- 13 Feb 23 Entry into a Material Definitive Agreement
- 10 Feb 23 Regulation FD Disclosure
Filing view
External links
Exhibit 16.1
February 13, 2023
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
We have read the statements under Item 4.01 of the Current Report on Form 8-K of Aesther Healthcare Acquisition Corp. to be filed with the Securities and Exchange Commission on or about February 14, 2023. We agree with all statements pertaining to us. We have no basis on which to agree or disagree with the other statements contained therein.
MaloneBailey, LLP
www.malonebailey.com
Houston, Texas